188 related articles for article (PubMed ID: 32927364)
1. Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis.
Wang J; Jiang Q; Faleti OD; Tsang CM; Zhao M; Wu G; Tsao SW; Fu M; Chen Y; Ding T; Chong T; Long Y; Yang X; Zhang Y; Cai Y; Li H; Peng M; Lyu X; Li X
Mol Ther Nucleic Acids; 2020 Aug; 22():153-165. PubMed ID: 32927364
[TBL] [Abstract][Full Text] [Related]
2. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.
Wang J; Liu Y; Zhang Y; Li X; Fang M; Qian D
Cancer Med; 2023 Jun; 12(11):12608-12621. PubMed ID: 37097161
[TBL] [Abstract][Full Text] [Related]
3. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
4. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway.
Dong M; Gong LP; Chen JN; Zhang XF; Zhang YW; Hui DY; Zhao XX; Wu XY; Shao CK
Cell Oncol (Dordr); 2020 Oct; 43(5):901-913. PubMed ID: 32533512
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting
Yang W; Tan S; Yang L; Chen X; Yang R; Oyang L; Lin J; Xia L; Wu N; Han Y; Tang Y; Su M; Luo X; Yang Y; Huang L; Hu Z; Tao Y; Liu L; Jin Y; Wang H; Liao Q; Zhou Y
Mol Ther Oncolytics; 2022 Mar; 24():612-623. PubMed ID: 35284624
[TBL] [Abstract][Full Text] [Related]
8. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI.
Duan B; Shi S; Yue H; You B; Shan Y; Zhu Z; Bao L; You Y
J Cancer; 2019; 10(26):6681-6692. PubMed ID: 31777597
[No Abstract] [Full Text] [Related]
10. EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma.
Lyu X; Wang J; Guo X; Wu G; Jiao Y; Faleti OD; Liu P; Liu T; Long Y; Chong T; Yang X; Huang J; He M; Tsang CM; Tsao SW; Wang Q; Jiang Q; Li X
PLoS Pathog; 2018 Dec; 14(12):e1007484. PubMed ID: 30557400
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis.
Zhou XJ; Xu HM; Huang GS; Lin BR
Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811
[TBL] [Abstract][Full Text] [Related]
12. Guggulsterone Promotes Nasopharyngeal Carcinoma Cells Exosomal Circfip1L1 to Mediate miR-125a-5p/VEGFA Affecting Tumor Angiogenesis.
Zhou T; Zhao S; Tang S; Wang Y; Wu R; Zeng X; Yang P; Zhang X; Tian X
Curr Mol Pharmacol; 2023; 16(8):870-880. PubMed ID: 36635928
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.
Luo WJ; He SW; Zou WQ; Zhao Y; He QM; Yang XJ; Guo R; Mao YP
Exp Biol Med (Maywood); 2021 Dec; 246(24):2618-2629. PubMed ID: 34424090
[TBL] [Abstract][Full Text] [Related]
15. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
16. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY
Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946
[TBL] [Abstract][Full Text] [Related]
17. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
Wang H; Wei X; Wu B; Su J; Tan W; Yang K
Cancer Manag Res; 2019; 11():3351-3360. PubMed ID: 31114371
[No Abstract] [Full Text] [Related]
18. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.
Mai S; Xiao R; Shi L; Zhou X; Yang T; Zhang M; Weng N; Zhao X; Wang R; Liu J; Sun R; Qin H; Wang H
Cell Death Dis; 2019 Oct; 10(11):819. PubMed ID: 31659158
[TBL] [Abstract][Full Text] [Related]
19. Effects of Co-Culture EBV-miR-BART1-3p on Proliferation and Invasion of Gastric Cancer Cells Based on Exosomes.
Lin M; Hu S; Zhang T; Li J; Gao F; Zhang Z; Zheng K; Li G; Ren C; Chen X; Guo F; Zhang S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345178
[TBL] [Abstract][Full Text] [Related]
20. Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport.
Gourzones C; Ferrand FR; Amiel C; Vérillaud B; Barat A; Guérin M; Gattolliat CH; Gelin A; Klibi J; Chaaben AB; Schneider V; Guemira F; Guigay J; Lang P; Jimenez-Pailhes AS; Busson P
Virol J; 2013 Apr; 10():119. PubMed ID: 23590857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
